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Abstract  38 
Background 39 
Dysautonomia is a disease characterised by degeneration of autonomic neurons.  40 
 41 
Methods  42 
The aim of this study was to perform a retrospective multicentre review of clinical data relating to cats and 43 
dogs diagnosed with dysautonomia and to evaluate their outcome. 44 
 45 
Results 46 
 Cats (n=34) and dogs (n=19) with clinical signs consistent with dysautonomia were considered for this 47 
retrospective study. Reported clinical findings included oesophageal and gastrointestinal dysmotility and 48 
distension, urinary retention, reduced or absent tear production, third eyelid protrusion and inappropriate 49 
mydriasis. Treatment was supportive, and included gastrointestinal prokinetics, feeding tube placement 50 
(oesophageal and percutaneous endoscopic gastrostomy tubes) and medications to treat urinary retention. 51 
The survival to discharge was 29% in cats and 47% in dogs. The overall survival in cats was 21% and 32% in 52 
dogs.  Survival of greater than two years was seen in six cats and three dogs.  53 
 54 
Conclusion  55 
This paper illustrates that some individuals are able to survive this disease and can have a good long-term 56 
prognosis, which is an infrequently reported finding for this disease. 57 
 58 
Introduction  59 
Dysautonomia is a term used to describe dysfunction of the autonomic nervous system (ANS). Pathologically, 60 
dysautonomia is characterised by neuronal degeneration.  61 
 62 
Dysautonomia has been reported worldwide in a variety of species including horses1, cats2 3, dogs4, hares5 and 63 
a llama6. The aetiology of dysautonomia in veterinary species remains uncertain, although a possible 64 
association with Clostridium botulinum (type C/D) neurotoxin has been described in horses and cats1 7 8.   65 
McGorum et al. (2017)9 reported that dysautonomic cats were deficient in sulpha-containing amino acids 66 
(methionine and cysteine/ cystine) despite an adequate dietary intake. They hypothesised this deficiency was 67 
due to consumption of an unidentified dietary neurotoxic mycotoxin or xenobiotic that resulted in the signs of 68 
dysautonomia as well as the deficiency in sulpha-containing amino acids 9. Outbreaks have been reported in 69 
both cats10 and dogs11 12 indicating possible contagion or interaction with/ ingestion of contaminated food, an 70 
environmental toxin or infectious pathogen (e.g. Clostridium botulinum type C neurotoxin).  71 
 72 
In both feline and canine dysautonomia commonly reported clinical signs include depression, anorexia or 73 
hyporexia, dysphagia, dysuria, regurgitation, vomiting, constipation, dilated and unresponsive pupils, third 74 
eyelid protrusion, dry nares and mucosae, reduced lacrimation, orthostatic hypotension, and bradycardia13 14 75 
15. Reduced anal tone has also been described, although less commonly, likely caused by denervation of the 76 
internal anal sphincter which is autonomically innervated. Non-autonomic nervous system signs such as ataxia 77 
and proprioceptive deficits have also been described in both cats and dogs13 16.  78 
  79 
Definitive diagnosis can be confirmed by post mortem identification of pathognomonic lesions in the ventral 80 
horns of the spinal cord, the autonomic ganglia and/or the brainstem nuclei4, 16. A histopathological ante 81 
mortem diagnosis can sometimes be made on full thickness intestinal biopsies. Findings in acute cases include 82 
neuronal chromatolytic degeneration and nuclear pyknosis, while neuronal loss and proliferation of satellite 83 
cells are seen in more chronic cases17.   84 
  85 
The aim of this study was to perform a retrospective multicentre review of clinical data relating to cats and 86 
dogs diagnosed with dysautonomia, and to evaluate the outcome in those patients. This is the first large scale 87 
study on feline and canine dysautonomia in the United Kingdom (UK) for over 30 years. Given improvements 88 
in veterinary practice, we wanted to evaluate whether previously reported high mortality rates persist. We 89 
also aim to describe patient characteristics, incidence of multiple-pet households being affected, diagnostic 90 
tests, rural or urban location and therapeutic interventions.  91 
 92 
 93 
Methods and materials  94 
Hospital records from the author’s referral clinics, between 2007 and 2016, were searched for cats and dogs 95 
with a clinical diagnosis of dysautonomia.  Data were extracted and collated in a spreadsheet; data collected 96 
included presenting signs, physical examination findings, clinicopathological findings, results of 97 
pharmacological testing results, outcome, management and details of husbandry. Address details were 98 
obtained to ascertain if location rural (i.e. primarily countryside), urban (i.e. city centre, minimal ‘green’ spaces) 99 
or semi-urban (i.e. relatively densely developed but with ready access to ‘green’ spaces), based on map 100 
examinations of the areas.     101 
 102 
Medical records were reviewed for presenting signs and physical examination findings consistent with 103 
dysautonomia, including gastrointestinal signs, urinary retention and respiratory signs, protrusion of the third 104 
eyelids, mydriasis, absent or delayed pupillary light response (PLR), bradycardia (defined as a heart rate less 105 
than 120 in cats and less than 70 in dogs18), altered anal tone, and excessively dry mucous membranes or nares. 106 
 107 
Pharmacological testing was performed as described by O’Brien and Johnson (2002)19 and Harkin et al. (2002)4. 108 
The pharmacological test used and results were extracted from the medical records when available.   109 
 110 
Cases were included when dysautonomia was considered the most plausible diagnosis for the clinical findings 111 
and when other possible differential diagnoses had been eliminated to the satisfaction of the attending 112 
clinician. A definitive post mortem diagnosis was available in some instances.   113 
 114 
Results  115 
A total of 53 cases were included; 34 cats and 19 dogs –   116 
Cats 117 
There were 19 male neutered, two male entire, eight neutered female and five entire female cats. Their 118 
median age was 3.9 years (range 17 weeks to 13 years and 4 months). There were 19 domestic shorthair cats, 119 
four Siamese, two Bengal, two Maine Coon, two Burmese and one each of Norwegian Forest cat, British 120 
Shorthair, British Blue, Burmilla and Ragdoll cat.  121 
 122 
Dogs 123 
There were seven male neutered, two male entire, three female neutered and seven female entire dogs. The 124 
median age was 3.3 years (range 7 months to 9 years and 3 months). There were three crossbreed dogs, three 125 
Labrador retrievers, two Cocker spaniels, two Jack Russell terriers, two border collies, and one each of Great 126 
Dane, West Highland White terrier, Japanese Shiba Inu, German Shepherd dog, Border terrier, Siberian Husky 127 
and Springer spaniel.  128 
 129 
Travel history was available for 24 cases; none had travelled outside the United Kingdom. 130 
 131 
Location  132 
A total of 13 cats and six dogs lived in a predominately urban environment; 14 cats and eight dogs lived 133 
predominately in a rural environment and seven cats and five dogs lived in a semi-urban environment.  134 
 135 
Multi-pet households 136 
A total of 19 animals were from multi-pet households. Nine cats were from multi-cat households where all in-137 
contacts were unaffected. One cat and one dog each lived with an unaffected dog. There were four instances 138 
where two individuals of the same species were affected in a single household (Table 1). Sixteen animals came 139 
from single pet households. Information regarding other pets in the household was not available for 18 cases. 140 
 141 
Table 1: Instances where more than one animal were affected by dysautonomia within the same household.  142 
Signalment  Clinical signs Time lapse  Treatment Outcome 
Two 11 year old 
Burmese cats, 
both neutered, 
one male and one 
female.  
Bilateral third eyelid 
protrusion, 
mydriasis, anorexia, 
lethargy, 
dehydration 
Male cat 
developed clinical 
signs two weeks 
prior to the female 
Supportive and 
symptomatic 
including 
oesophageal 
feeding tube 
placement 
Both cases euthanised. Post 
mortem examinations; the male 
had changes consistent with 
dysautonomia, whereas 
insufficient ganglia were examined 
for a definitive diagnosis in the 
female. 
Two Siamese cats, 
both were 
neutered females, 
one five years old, 
one 11 years old. 
Vomiting, anorexia, 
dry nares, bilateral 
mydriasis with third 
eyelid protrusion 
Developed clinical 
signs concurrently  
Gastrointestinal 
prokinetics, PEG 
tube placement 
and antiemetics 
The younger cat was euthanised 
after eight days; no post mortem 
examination was performed. The 
older cat was euthanised 186 days 
later due to an unrelated disease, 
all dysautonomia signs resolved. 
Two one year old 
male neutered 
domestic short 
haired cats 
Constipation, 
dehydration, 
xerostomia, third 
eyelid protrusion, 
anorexia, vomiting 
and regurgitation 
Developed clinical 
signs concurrently 
None  Both were euthanised on the day 
of presentation and post mortem 
examinations confirmed 
dysautonomia. 
Two year old 
female Border 
terrier and a two 
year 6 month old 
female 
Labradoodle 
Vomiting, diarrhoea, 
lethargy, anorexia, 
altered anal tone, 
ulcerative keratitis 
secondary to absent 
tear production and 
pollakiuria 
Developed clinical 
signs concurrently 
Bethanecol, 
metoclopramide 
and ocular ulcer 
management. The 
labradoodle also 
received 
metronidazole.  
Border terrier failed to respond to 
treatment and was euthanised 
after five days. The Labradoodle 
made a progressive return to 
normality; this case is still alive 
one year and one month following 
discharge. 
 143 
 144 
Duration of illness prior to referral 145 
Information regarding duration of illness prior to referral was available for all but two cats and one dog. The 146 
median time to referral after the onset of clinical signs was 13.5 days (range 0-60 days) for cats and 32.3 days 147 
(range 2-365 days) for dogs. 148 
 149 
Presenting signs, physical examination findings, pharmacological testing and diagnostic imaging 150 
results 151 
Reported presenting signs are detailed in Table 2 (cats) and Table 3 (dogs), while reported ocular signs are 152 
detailed in Table 4.  153 
 154 
Table 2: Presenting signs recorded for cats with dysautonomia 155 
Presenting sign Number of cats 
affected (total 34) 
[%] 
Data not available 
(no. of cats)  
Anorexia or hyporexia  24 [92] 8 
Vomiting or regurgitation  29 [85] 0 
Constipation  17 [55] 3 
Nasal discharge or crusting 13 [46] 6 
Lower urinary tract signs   13 [43] 4 
Respiratory signs  11 [37] 4 
Bradycardia  10 [30] 1 
Altered anal tone  4 [20] 14 
Diarrhoea  5 [16] 3 
 156 
 157 
Table 3: Presenting signs recorded for dogs with dysautonomia 158 
Presenting sign Number of dogs 
affected (total 19) 
[%] 
Data not available 
(no. of dogs)  
Anorexia or hyporexia  10 [100] 9 
Vomiting or regurgitation  17 [94] 1 
Lower urinary tract signs   14 [82] 2 
Altered anal tone  8 [73] 8 
Diarrhoea  12 [67] 1 
Nasal discharge or crusting 9 [56] 3 
Respiratory signs  8 [44] 1 
Bradycardia  1 [6] 1 
Constipation  1 [6] 3 
 159 
 160 
Table 4: Specific ocular signs in dogs and cats  161 
Key: PLR - pupillary light response; STT – Schirmer tear test 162 
Ocular sign Number of cats 
affected (total 34) 
[%] 
Result not 
available (no. of 
cats) 
Number of dogs 
affected (total 19)  
[%] 
Result not 
available (no. of 
dogs) 
Abnormal STT 26 [90] 5 12 [86] 5 
Absent or delayed PLR   15 [88] 17 8 [73] 8 
Pilocarpine response test 19 [86] 12 8 [73] 8 
Mydriasis  22 [81] 7 6 [55] 8 
Third eyelid protrusion  20 [77] 8 9 [60] 4 
 163 
 164 
Cats and dogs presented with broadly similar signs, with vomiting or regurgitation (85% cats; 94% dogs) and 165 
hyporexia (92% cats; 100% dogs) common in both species. Urinary tract signs were reported in both species, 166 
but were more common in dogs than cats (43% cats; 82% dogs).  167 
 168 
The Schirmer Tear Test (STT) was commonly utilised. It was found to be abnormal (<15mm in 60 seconds), in 169 
at least one eye, in 90% of cats and 86% of dogs tested. An ocular pilocarpine response test was used as a 170 
diagnostic aid in 22 cats, and was reported to be consistent with dysautonomia by the attending clinician in 19 171 
cases (86%), and 11 dogs, with a result consistent with dysautonomia in 8 cases (73%). An atropine response 172 
test was performed in three cats, one with a resting heart rate of 52 thus meeting the bradycardia inclusion 173 
criteria, and two with a rate greater than 120 beats per minute but considered to be inappropriately 174 
bradycardic by the attending clinician (136 and 140 beats per minute). There was no response to atropine in 175 
all three cats, indicating a lack of appropriate sympathetic input to the heart. A histamine response test has 176 
been described in the literature4 12 19 20 but was not utilised in any of the cases. Additionally, acetylcholine 177 
receptor antibodies were not measured in any of the cases reviewed.  178 
 179 
Diagnostic imaging modalities employed included thoracic radiography (cats n=25, dogs n=12), abdominal 180 
radiography (cats n=11, dogs n=8), abdominal ultrasound (cats n=20, dogs n=9) and, less commonly, 181 
computerised tomography (cats n=6, dogs n=1). Aspiration pneumonia was identified using thoracic imaging 182 
in 13% cats (n=4) and 31% of dogs (n=4), while megaoesophagus was identified in 65% of cats (n=20) and 23% 183 
of dogs (n=3). Abdominal imaging identified gastrointestinal dilation with gas or fluid in nine cats and five dogs, 184 
excess faeces consistent with colonic hypomotility in three cats and one dog, and urinary bladder distension 185 
in three cats and one dog.  186 
 187 
Treatment 188 
Various treatments and medications were utilised to help manage the clinical signs associated with 189 
dysautonomia in this study. Non-specific supportive treatments such as intravenous fluid therapy and ocular 190 
lubrication were not specifically recorded.    191 
 192 
Hospitalisation  193 
Overall, cases were hospitalised for a median of three days (range 0-29). Cases that survived and experienced 194 
a resolution of their clinical signs were hospitalised for a longer median period (median six days, range 0-11) 195 
compared with those cases that died (median 2.9 days, range 0-29). Additionally, 50% of the cases that 196 
survived were hospitalised for seven days or more compared to only 16% of the cases that died. Information 197 
regarding the duration of hospitalisation was not available for five cases.  198 
 199 
Gastrointestinal dysmotility  200 
Gastrointestinal prokinetic medications were commonly prescribed to animals with gastrointestinal 201 
dysmotility. Cisapride (Cisapride®; Summit Veterinary Pharmaceuticals) was given to 10 cats and one dog, 202 
metoclopramide (Emeprid®; Ceva) prescribed to 12 cats and nine dogs, and ranitidine (Zantac®; 203 
GlaxoSmithKline) prescribed to 10 cats and four dogs. Two dogs and 10 cats received multiple gastrointestinal 204 
prokinetic medications.  205 
 206 
Maropitant (Cerenia®; Zoetis) was prescribed to reduce nausea/ vomiting in four cats and four dogs. 207 
Omeprazole (Losec®; AstraZeneca) was employed as a gastric protectant in six cats and one dog.  208 
 209 
Lactulose (Lactulose; Sandoz) was administered to three cats and one dog to manage constipation and in one 210 
cat for suspected hepatic encephalopathy secondary to hepatic lipidosis.  211 
 212 
Urinary retention  213 
Bethanecol (Myotonine®; Glenwood GMBH) was prescribed in nine cats and five dogs, prazosin (Hypovase®; 214 
Pfizer) in two cats and two dogs, and phenoxybenazmine (Dibenyline®; Dales Pharmaceuticals Ltd) to one cat. 215 
 216 
Other medications and management strategies  217 
Antimicrobials were administered to nine cats and 11 dogs most commonly to treat suspected or confirmed 218 
aspiration pneumonia. Prednisolone (Prednidale®; Dechra) was prescribed to two dogs; one due to concurrent 219 
immune mediated haemolytic anaemia, the reason was not recorded in the second patient. Feeding tubes, 220 
either percutaneous endoscopic gastrostomy (PEG) tubes or oesophageal tubes, were placed in 18 cats (of 221 
which five survived to discharge) and three dogs (of which two survived to discharge). Feeding tube 222 
complications were only reported in one cat; failure of stoma formation following PEG tube removal 223 
contributed to the decision for euthanasia in this case. Long term (minimum of 186 days) resolution of clinical 224 
signs was seen in four cases in which feeding tubes were placed (PEG n= 3, oesophageal n=1).  225 
 226 
Of the cats which survived to discharge three were euthanised within eight days due to signs consistent with 227 
dysautonomia/ poor response to treatment. The remaining two had long-term resolution of their clinical signs 228 
(at least seven month follow up in both cats). Of the dogs which survived to discharge clinical signs resolved in 229 
one case who survived at least three years and 11 months post discharge. Follow up information is not available 230 
for the other dog.   231 
 232 
Exploratory laparotomies were performed in four dogs and one cat prior to referral. In all instances the small 233 
intestinal/ gastric dilation seen on diagnostic imaging was considered compatible with an intestinal obstruction 234 
prior to surgery. No evidence of underlying gross pathology was identified during these surgeries. Of these 235 
patients, only one dog survived to discharge, the rest were euthanised due to clinical signs consistent with 236 
dysautonomia. Aspiration pneumonia was diagnosed in one of these dogs; PEG tubes were placed in two of 237 
these dogs. 238 
 239 
Survival 240 
Cats 241 
Of the 34 cats included in this study, 10 survived to discharge (29%). Three of these 10 cats were euthanised 242 
within eight days of discharge due to progressive signs consistent with dysautonomia. One case was euthanised 243 
186 days following discharge from hospital due to suspected triaditis, with the dysautonomia having resolved. 244 
There was complete and long-term (greater than two years) resolution of dysautonomia in six cases, which are 245 
discussed below.  246 
 247 
Dogs  248 
Of the 19 dogs included in this study, nine dogs survived to discharge (47%). Two cases were euthanised the 249 
week following discharge due to progressive clinical signs consistent with dysautonomia. One dog was 250 
euthanised seven months after discharge due to progressive clinical signs. One dog had resolution of clinical 251 
signs within two months of presentation and this case is still alive with no clinical signs 11 months following 252 
discharge. One dog had resolution of clinical signs within seven days of discharge but was lost to follow up. 253 
Long-term survival (greater than two years) was seen in three patients who are discussed below. Follow up 254 
information was not available for the remaining case.  255 
 256 
Long Term Survivors  257 
Survival longer than two years was seen in six cats and three dogs (Table 5). One dog required on-going ocular 258 
lubricants as tear production never recovered. All other cases had complete resolution of their presenting signs 259 
and did not require any long-term treatments.  260 
 261 
Table 5: Long term survivors of canine and feline dysautonomia 262 
Key: STT - Schirmer tear test; DSH – domestic short hair; PLR - pupillary light response; PEG – percutaneously placed gastrostomy tube 263 
Signalment  Clinical Signs  Diagnostic 
imaging 
STT Pilocarpine 
response test  
Treatment  Outcome  
One year 
old, 
Vomiting, regurgitation, 
lethargy, coughing, 
mydriasis, absent PLR, 
Thoracic 
radiographs and 
abdominal 
R 4mm/min  
L 11mm/min 
No ocular 
response (% 
dilution and the 
Postural feeding 
from a height and 
ranitidine. 
Improvement over 
months until 
complete resolution 
neutered 
female DSH 
protrusion of the third 
eyelid, constipation and 
crusty/dry nares.  
ultrasound were 
within normal 
limits 
time taken not 
recorded). 
of clinical signs. 
Patient alive at the 
time of publication 
four years after 
discharge. 
Four year 
old, 
neutered 
male DSH 
Vomiting, lethargy, 
inappetence, dysuria, 
pollakiuria, bilateral 
mydriasis, third eyelid 
protrusion, dysphagia 
and absent PLRs. 
Abdominal/ 
thoracic 
radiography: 
distended 
bladder, 
otherwise 
unremarkable. 
Abdominal 
ultrasound 
unremarkable. 
R 0mm/min  
L 0mm/min 
Not performed  Gastrointestinal 
signs self-resolved. 
Bethanecol, 
phenoxybenzamine 
and alprazolam for 
urinary signs.  
Normal micturition 
returned over the 
proceeding weeks. 
PLR started to return 
eight months later.  
Patient is alive and 
asymptomatic six 
years and three 
months later. 
Nine month 
old, female 
neutered 
DSH 
Hyporexia, dysphagia, 
tenesmus, coughing, 
sneezing, weakness, 
xerostomia, tachypnoea, 
reduced anal tone, third 
eyelid protrusion and 
marked mydriasis. 
Thoracic 
radiographs: 
megaoesophagus. 
Abdominal 
ultrasound 
unremarkable.  
R 0mm/min  
L 0mm/min 
Miosis within 
nine minutes (% 
not recorded). 
Ranitidine, 
cisapride, 
antimicrobials, PEG 
tube placement. 
Clinical signs gradually 
resolved. Patient was 
euthanised three 
years and seven 
months after 
diagnosis due to 
development of 
arterial 
thromboembolism of 
unknown aetiology. 
Four year 
old, male 
neutered 
Bengal cat  
Hyporexia, third eyelid 
protrusion, lethargy, 
sneezing, bradycardia 
(heart rate 100 beats per 
minute) and a bilateral, 
clear nasal discharge. 
Abdominal 
ultrasound 
unremarkable. 
Not 
performed 
Not performed  Extremely fractious 
patient; owner 
unable to 
medicate, 
consequently no 
treatment 
prescribed. 
Recovered over a few 
months until all 
clinical signs fully 
resolved. Clinically 
well four years and 
three months 
following discharge 
18 month 
old, male 
neutered 
DSH 
Anorexia, lethargy, 
weight loss, mydriasis, 
dry nares, absent PLRs 
and dehydration.  
Thoracic 
radiography and 
abdominal 
ultrasound were 
both 
unremarkable. 
Fluoroscopy; 
reduced 
oesophageal 
motility 
R 0mm/min  
L 0mm/min 
Miosis achieved 
(% dilution and 
the time taken 
not recorded). 
Oesophageal 
feeding tube 
placement, 
cisapride and 
ocular lubricant 
Hospitalised for 11 
days. Cisapride 
continued for six 
months. Case lost to 
follow up three years 
and seven months 
later; at this time 
clinical signs had 
resolved. 
Four year 
old, male 
neutered 
DSH 
Two month history of 
faecal incontinence, 
third eyelid protrusion, 
bradycardia (heart rate 
96-116 beats per 
minute), occasional 
vomiting and diarrhoea 
None performed  R 0mm/min  
L 0mm/min 
Not performed  Ocular lubrication 
alone 
Clinical signs resolved 
over approximately a 
six month period. This 
individual is still alive 
at the time of 
publication, five years 
and six months 
following discharge.  
Eight 
month old, 
female 
Labrador 
Initially only dysuria, 
stranguria, urinary 
retention, then 
developed xerostomia, 
vomiting, regurgitation, 
diarrhoea, hyporexia, 
lethargy, corneal 
ulceration, bilateral 
purulent ocular and 
nasal discharge and mild 
generalised ataxia. 
None performed  Noted to be 
“reduced” 
but values 
not 
recorded  
Not performed  Prazosin and ocular 
ulcer management.  
Alive two years 
following discharge, 
resolution of urinary 
signs, dry-eye 
management on-
going. 
Seven 
months 
old, female 
Labrador  
Diarrhoea, vomiting, 
coughing, pollakiuria. 
Tachypnoea, harsh lung 
sounds on auscultation, 
bilateral third eyelid 
protrusion, absent PLRs 
and a reduced gag reflex. 
Thoracic 
radiographs 
unremarkable.  
Not 
performed  
Miosis within 30 
minutes (% not 
recorded). 
Metoclopramide 
constant rate 
infusion, 
amoxicillin 
clavulanate, 
maropitant and 
omeprazole. PEG 
tube placement   
Five days of 
hospitalisation. PEG 
tube removed after 7 
weeks, clinical signs 
had resolved. Still 
alive and 
asymptomatic three 
years and 11 months 
following the initial 
presentation. 
Five year 
old, female 
neutered 
Border 
collie 
Lethargy, hyporexia, 
dysuria, stranguria, 
urinary incontinence, 
coughing, dysphagia, 
increased upper 
respiratory tract noise, 
bilateral third eyelid 
protrusion and 
decreased anal tone.  
Abdominal 
ultrasound was 
unremarkable, 
mild aspiration 
pneumonia was 
identified on 
computerised 
tomography. 
Not 
performed  
Not performed  Oxygen therapy 
and broad 
spectrum 
antimicrobials. 
Alive three years 
following discharge 
but third eyelid 
protrusion, decreased 
anal tone and dysuria 
remain static.  
 264 
Post Mortem examination 265 
Post mortem examinations were performed in 12 cats and two dogs. Feline dysautonomia was definitively 266 
diagnosed at post mortem in 10 cases and canine dysautonomia in two cases. In two cats, the post mortem 267 
findings were inconclusive; in one case insufficient nervous tissue was provided for examination and in the 268 
second there were some features consistent with dysautonomia, such as a diffuse reduction in the number of 269 
neurones, but this was deemed insufficient for a definitive diagnosis. The findings were consistent with the 270 
previous reports14 15, including neurone depletion within the autonomic ganglia, affected cells showed 271 
chromatolysis, vacuolated cytoplasm, cell shrinkage and pyknotic nuclei. No infectious organisms were 272 
identified.  273 
 274 
Post mortem examinations were not performed in the remaining 22 cats and 17 dogs, however, the disease 275 
was strongly suspected based on clinical signs and results of pharmacological testing.  276 
 277 
Clinical Significance   278 
This is the first large scale multicentre study of canine and feline dysautonomia from the UK in over 30 years. 279 
Dysautonomia remains a rare diagnosis in general and referral practice. However, given the challenges 280 
associated with a definitive diagnosis and spontaneous regression in some animals, it is possible that mildly 281 
affected individuals are treated symptomatically without dysautonomia being considered. This paper may 282 
therefore be a poor representation of all dysautonomia cases, having been biased towards more severely 283 
affected animals. Nevertheless, it is important to raise awareness of dysautonomia as a differential diagnosis 284 
in animals with gastrointestinal signs, in order to prevent unnecessary diagnostic tests and associated 285 
morbidity.  286 
 287 
Achieving a definitive ante mortem diagnosis of dysautonomia relies on histopathological examination of full 288 
thickness intestinal biopsies, including assessment of the mesenteric plexus. Otherwise, diagnosis is reliant on 289 
histological identification of pathognomonic lesions in the spinal cord, autonomic ganglia and/ or the 290 
brainstem nuclei, none of which can be performed ante mortem. Intestinal biopsies were not performed in 291 
any of the cases included in this study, therefore diagnosis was based on the attending clinician’s ability to 292 
ruling out other differential diagnoses (unless a post mortem examination was available to confirm the 293 
diagnosis). 294 
 295 
This study does have some inherent weaknesses; it is retrospective and multicentre resulting in incomplete 296 
data in some instances, and a lack of standardisation of investigations and treatments. There is a paucity of 297 
definitively agreed diagnostic criteria or testing for the ante mortem diagnosis of dysautonomia. Therefore, 298 
misdiagnosis in some of the cases included in this study is possible. It is probable that only the most severely 299 
affected individuals were referred on to specialist intuitions, introducing bias into the patient population. It is 300 
therefore feasible that the prognosis of dysautonomia is better than is reported in the veterinary literature. 301 
Further studies including data from general practitioners are required.  302 
 303 
The signalment in this paper is similar to previously reported13 15 16 21. Domestic shorthair cats were the most 304 
commonly represented breed, which probably reflects their higher prevalence. In contrast with the population 305 
presented by Nash (1987)22 where 75% of feline cases were less than three years of age, our median age at 306 
presentation was greater than three years, however, the vast majority of cats (79%) were less than seven years 307 
of age.   308 
  309 
In dogs, the Labrador retriever and cross breed dogs were the most commonly represented. The Labrador 310 
retriever has been identified in two previous studies as possibly being over represented13 23; however, it is also 311 
a very popular breed of dog in the UK. As with feline dysautonomia, younger dogs are reportedly over 312 
represented4 11 12 13 14 21 23 24 25. This was loosely supported in the current study, given that 79% of cases were 313 
less than seven years of age.   314 
 315 
Cases were fairly evenly distributed between rural and urban environments. It is possible that dogs who lived 316 
in an urban environment were exposed to rural environments during exercise. A previous paper reported that 317 
dogs with dysautonomia were more likely to come from rural areas23.    318 
 319 
There were four instances where two animals of the same species within a single household were affected. 320 
Dysautonomia outbreaks have been reported in both cats10 and dogs11 12. The mechanism that results in 321 
multiple animals becoming affected remains unknown10 11 12. Where dysautonomia affects an individual in a 322 
multi-animal household, the owner should be advised to be extra vigilant for developing clinical signs in any 323 
in-contact animals.  324 
 325 
As previously reported, the duration of clinical signs prior to referral was quite variable, perhaps indicating 326 
acute and chronic presentations of the condition16 19. This also appeared to be longer in dogs which perhaps 327 
indicates that dysautonomia can have a more insidious onset in this species.  328 
 329 
The patients in this study had the same common presenting and physical examination findings as previously 330 
reported4 16. There were differences, as would be expected, in the incidence of some signs between the 331 
species, for example, constipation was relatively common in cats (n=17), but reported in only one dog, while 332 
diarrhoea was infrequently reported in cats. Signs consistent with urinary retention, such as dysuria and 333 
pollakiuria, were reported in 12 cats and 14 dogs. It is possible that in cats this clinical sign is more common 334 
than described as urination in this species is often unobserved by the owner. 335 
 336 
The exact prevalence of some clinical signs is hard to ascertain in a retrospective study because subtler clinical 337 
signs, such as dry mucosae and third eyelid protrusion, might not be recorded in the clinical notes, thus 338 
underestimating their true prevalence.    339 
 340 
Reduced or absent tear production is a recognised feature of dysautonomia in both cats and dogs4 16. A STT 341 
was used to document reduced tear production in this paper as in previous publications4 11. This is an 342 
economical and simple test to build evidence for an ante mortem diagnosis of dysautonomia. It is important 343 
to note that low STT values have been reported in normal cats; while Crispin (2007)26 advised that values of 344 
approximately 12mm (+/-5) over 60 seconds are normal, Sebbag et al. (2015)27 concluded that an abnormal 345 
tear film should be suspected in this species when STT readings are less than 9mm over 60 seconds. Because 346 
of this, the STT as a diagnostic aid in this species is questionable.  However, it has been included in previous 347 
studies on feline dysautonomia10 15, hence the inclusion of the data in this study. 348 
 349 
Pharmacological testing was used frequently in this study to provide additional evidence to support the 350 
suspected diagnosis. Pilocarpine is a direct-acting parasympathomimetic agent, that stimulates the cholinergic 351 
receptors in the iris causing miosis when applied topically. In dysautonomia, there is degeneration of the 352 
postganglionic neurones which results in enhanced sensitivity of the denervated muscle to cholinergic drugs19. 353 
This hypersensitivity enables dysautonomic animals to respond to a diluted solution of pilocarpine. O’Brien 354 
and Johnson (2002)19 used a 0.05% solution of pilocarpine and considered the “rapid” development of miosis 355 
consistent with dysautonomia. They also note that it is possible for normal dogs to respond to this 356 
concentration, but that it would take 45 to 60 minutes for this to happen19. Harkin and others (2002)4 used a 357 
0.1% solution and considered a positive result as miosis within 30 minutes4. The retrospective nature of the 358 
current study prevented the utilisation of a standardised protocol for this pharmacological test, this was a 359 
limitation of this study. This test aided diagnosis in 19 cats and eight dogs where the patient demonstrated 360 
miosis within a time frame (miosis/ resolution of third eyelid protrusion within 45 minutes) and in response to 361 
a suitable concentration of pilocarpine, to be considered appropriate by the attending clinician for 362 
dysautonomia.  363 
 364 
Bogucki and Noszczyk-Nowak (2017)28 explain that the heart is principally regulated by the parasympathetic 365 
nervous system under physiological conditions.  Atropine, a direct acting parasympatholytic agent, blocks the 366 
action of acetylcholine at the muscarinic receptors in the parasympathetic nervous system. Under normal 367 
circumstances, when given by intravenous or intramuscular injection, it causes an increase in heart rate as the 368 
sympathetic nervous system becomes dominant. Dysautonomia can cause a loss of sympathetic nervous 369 
system innervation to the heart; consequently, no change in heart rate is seen in response to the 370 
administration of atropine4. Atropine was utilised in only three cases in this study and in all cases, there was 371 
no increase in heart rate, supporting the diagnosis of dysautonomia.  372 
 373 
All three of the canine long-term survivors presented with both gastrointestinal and urinary signs. However, in 374 
this species, the clinical signs associated with either the urinary tract or gastrointestinal tract, persisted and 375 
required further management. For example, the first canine case, an eight month old, female entire Labrador, 376 
presented with vomiting and dysuria but only received specific treatment for the latter. Only one of the feline 377 
long-term survivors had involvement of both the urinary and gastrointestinal tracts; a four year old, male 378 
neutered domestic shorthaired cat who presented with vomiting, anorexia, pollakiuria and dysuria in addition 379 
to third eyelid prolapse and bilateral mydriasis. In this case the gastrointestinal signs self-resolved and specific 380 
treatment was only given to manage the urinary tract signs. All the other long-term feline survivors had clinical 381 
signs limited to a single body system alone. This might indicate that the prognosis is improved when persistent 382 
clinical signs are limited to one body system. 383 
 384 
Treatments prescribed to patients in this study are comparable to those that have been reported previously4 385 
12 13 14 15 29. As the aetiology of dysautonomia is yet to be fully established, treatment is exclusively supportive 386 
and symptomatic.  387 
 388 
The mortality rate in this study was high, agreeing with previous reports15 16, and demonstrating that 389 
dysautonomia remains a highly challenging condition to treat. However, some cases were euthanised once the 390 
diagnosis was obtained due to the previously reported high mortality rate, this could result in an artificially 391 
poorer prognosis. This observation is supported by the fact that cases who survived were hospitalised for a 392 
longer median period and that 84% of the cases that died were hospitalised for less than seven days compared 393 
to 50% of the cases that survived. In this study 29% of cats and 47% of dogs survived to discharge. Our survival 394 
rate in dogs is much higher than previously reported, and may represent improvements in case management 395 
or changing attitudes toward disease.  396 
 397 
There were nine long-term survivors (six cats and three dogs). All the long-term survivors had a combination 398 
of consistent clinical signs which would be hard to attribute to any other single disease process, and had a 399 
clinical diagnosis made by exclusion of other causes.   400 
 401 
This is a large, multi-centre study that provides up dated information regarding this often devastating 402 
condition. Patients frequently display a range of clinical signs, none of which are pathognomonic, making an 403 
ante mortem diagnosis challenging. However, the presence of ocular signs (i.e. inappropriate mydriasis, third 404 
eyelid prolapse) in combination with lower urinary tract signs or megaoesophagus/ regurgitation does seem 405 
to be highly supportive of dysautonomia. This disease remains a relatively uncommonly diagnosed condition 406 
with a high mortality rate. The presentation of this disease in more than one animal in a single household could 407 
possibly indicate a degree of contagion or exposure to a common toxin or environmental contaminant. 408 
Prospective long-term studies are required to gain more information about the best way to treat this disease 409 
in domestic species, however the rarity of this disease will make this challenging.  410 
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